• 1. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

Introduction to 2-(6-Methoxy-1-benzofuran-3-yl)acetic Acid (CAS No. 69716-05-8)

2-(6-Methoxy-1-benzofuran-3-yl)acetic acid, with the CAS number 69716-05-8, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as MBA (Methoxybenzofuranacetic acid), is characterized by its unique structural features, which include a benzofuran ring and a methoxy substituent. These properties make it an intriguing candidate for various applications, particularly in the development of novel therapeutic agents.

The molecular formula of 2-(6-Methoxy-1-benzofuran-3-yl)acetic acid is C₁₁H₁₀O₄, and its molecular weight is approximately 206.19 g/mol. The compound exhibits excellent solubility in polar solvents such as methanol and dimethyl sulfoxide (DMSO), which facilitates its use in various chemical and biological assays. Its physical properties, including melting point and solubility, have been extensively studied and documented, providing a solid foundation for further research and application.

In recent years, the study of 2-(6-Methoxy-1-benzofuran-3-yl)acetic acid has expanded to encompass a wide range of biological activities. One of the most notable areas of research is its potential as an anti-inflammatory agent. Studies have shown that this compound possesses significant anti-inflammatory properties, which are attributed to its ability to inhibit the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). This makes it a promising candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Beyond its anti-inflammatory properties, 2-(6-Methoxy-1-benzofuran-3-yl)acetic acid has also been investigated for its potential anticancer effects. Research has demonstrated that this compound can induce apoptosis in various cancer cell lines, including breast cancer, colon cancer, and lung cancer cells. The mechanism of action involves the modulation of key signaling pathways such as the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. These findings suggest that MBA could be a valuable lead compound for the development of new anticancer drugs.

The pharmacokinetic properties of 2-(6-Methoxy-1-benzofuran-3-yl)acetic acid have also been explored in preclinical studies. These studies have shown that the compound has favorable absorption, distribution, metabolism, and excretion (ADME) profiles, which are crucial for its potential therapeutic applications. Additionally, toxicity studies have indicated that MBA exhibits low toxicity at therapeutic doses, further supporting its safety profile.

In the context of drug discovery and development, 2-(6-Methoxy-1-benzofuran-3-yl)acetic acid has been used as a starting point for structure-based drug design. Researchers have synthesized various derivatives of this compound to enhance its biological activity and improve its pharmacological properties. For example, modifications to the methoxy group or the benzofuran ring have led to compounds with enhanced anti-inflammatory and anticancer activities. These efforts highlight the potential of MBA as a scaffold for the development of novel therapeutic agents.

The environmental impact of 2-(6-Methoxy-1-benzofuran-3-yl)acetic acid has also been considered in recent studies. While no significant environmental concerns have been reported, ongoing research is focused on ensuring that any potential environmental effects are minimized through sustainable synthesis methods and responsible disposal practices.

In conclusion, 2-(6-Methoxy-1-benzofuran-3-yl)acetic acid (CAS No. 69716-05-8) is a promising compound with diverse biological activities and potential therapeutic applications. Its unique structural features and favorable pharmacological properties make it an attractive candidate for further research and development in the fields of medicinal chemistry and pharmaceutical science. As research continues to advance, it is likely that new insights into the mechanisms of action and potential uses of this compound will emerge, further solidifying its importance in modern drug discovery efforts.

• 92262-75-4(Naphtho2,1-bfuran-1-yl-acetic acid)
• 142917-39-3(2-(6-methyl-1-benzofuran-3-yl)acetic acid)
• 39581-49-2(Methyl 2-(7-methoxybenzofuran-3-yl)acetate)
• 882248-24-0(2-(5-ethyl-1-benzofuran-3-yl)acetic Acid)
• 726174-52-3(methyl 2-(6-hydroxy-1-benzofuran-3-yl)acetate)
• 56798-52-8(2-Propanone, 1-(5-methoxy-3-benzofuranyl)-)
• 1380390-22-6(Methyl 2-(6-hydroxy-4-methylbenzofuran-3-yl)acetate)
• 64175-51-5(2-(1-benzofuran-3-yl)acetic acid)
• 539807-37-9(2-(4,6-dimethyl-1-benzofuran-3-yl)acetic acid)
• 69716-04-7(2-(6-hydroxy-1-benzofuran-3-yl)acetic acid)